ALPHARETTA, Ga., March 29, 2019 /PRNewswire-PRWeb/ -- After extensive research and development, Pharm Origins has announced
Conolidine, a naturally occurring alkaloid, has been vastly studied for its ability to suppress pain like popular opiates without side effects or addiction risk.
It is specifically a C5 nor stemmadenines, which is an opioid analgesics, reportedly providing powerful relief without side effects or addiction.
Pharm Origins has recently filed patents on a nutrient extraction system that is able to extract active ingredients from the world's rarest, most fragile natural sources.
This cutting-edge process was used in the extraction of conoldine.
"We have been following the research evolution of conolidine since 2011 and the clinical results have been incredible. We are proud that we have the technology to isolate this very important compound," said Clint Winters, natural health researcher and Pharm Origins spokesperson.
He went on to say, "It is our goal to be able to provide a sublingual formula that will give our customers potent and safe relief."
The breakthrough comes in the midst of a terrible opioid epidemic ravaging American citizens and families.
"We view sublingual conolidine as a safe and potent alternative to the world's most dangerous pain killing medications," said Travis Shoaf, Director of Manufacturing and Fulfillment for Pharm Origins. "Seeing this compound developed in our lab has been truly exciting."
Pharm Origins will continue to research and perfect the extraction of conolidine to ultimately create a breakthrough natural relief formula.
A 2019 release date for this formula is currently projected.
Pharm Origins was founded in 2011 and is an FDA registered dietary supplement formulator and manufacturer located in Atlanta, GA.
SOURCE Pharm Origins
Subscribe to our Free Newsletters!